Jennifer Kamocsay
General Counsel at AKOYA BIOSCIENCES, INC.
Net worth: 232 168 $ as of 2024-06-29
Jennifer Kamocsay active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AKOYA BIOSCIENCES, INC. | General Counsel | 2023-02-27 | - |
Career history of Jennifer Kamocsay
Former positions of Jennifer Kamocsay
| Companies | Position | Start | End |
|---|---|---|---|
| PROGRESS SOFTWARE CORPORATION | Corporate Officer/Principal | - | - |
| RUBIUS THERAPEUTICS | General Counsel | - | - |
Training of Jennifer Kamocsay
| University of California | Undergraduate Degree |
| Northeastern University School of Law | Graduate Degree |
Statistics
International
| United States | 6 |
Operational
| General Counsel | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AKOYA BIOSCIENCES, INC. | Health Technology |
| PROGRESS SOFTWARE CORPORATION | Technology Services |
| Private companies | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Kamocsay
- Experience
